U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 37.00
-1.00 (-2.63%)
Apr 2, 2026, 1:30 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1.09 billion as of April 2, 2026. Its market cap has decreased by -4.76% in one year.
Market Cap
1.09B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
37.00
Market Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has decreased from 1.36B to 1.09B, a decrease of -19.57%. That is a compound annual growth rate of -7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.09B | -2.37% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.38B |
| Enimmune | 1.36B |
| Great Novel Therapeutics Biotech & Medicals | 1.31B |
| Meribank Biotech | 1.20B |
| GeneReach Biotechnology | 1.13B |
| Lukas Biomedical | 1.09B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.01B |